Market Research Logo

Gaucher's Market Research Reports & Industry Analysis


Gaucher's Industry Research & Market Reports

  • Lysosomal Disease Treatments: Technologies and Global Markets

    ... further segmented into Hunter syndrome, Hurlers Syndrome and Moriquo syndrome. The market is also segmented by routing of administration into IV and oral. The market has been divided into hospitals, clinics and other facilities into ... Read More

  • Gaucher Disease - Pipeline Review, H1 2018

    ... pipeline landscape. Gaucher disease is a rare genetic disorder occurs due to lacks an enzyme called glucocerebrosidase. Symptoms include cognitive impairment, enlarged spleen, severe swelling, lung disease, fatigue and seizures. Treatment includes enzyme replacement therapy. ... Read More

  • Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)

    ... abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & ... Read More

  • Gaucher Disease Type I Global Clinical Trials Review, H2, 2017

    ... trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease Type I. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More

  • Gaucher Disease Global Clinical Trials Review, H2, 2017

    ... line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More

  • Gaucher's Disease Pipeline Highlights – 2017 Update

    ... It covers emerging therapies for Gaucher's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, ... Read More

  • Europe Gaucher's Disease Market and Competitive Landscape – 2017

    ... product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Gaucher's Disease market size and drug sales. This research also provides insights into Gaucher's Disease epidemiology and late stage pipeline. ... Read More

  • Global Gaucher Disease Industry 2017 Market Research Report

    ... six-year historic analysis is provided for these markets. The global market for Gaucher Disease is expected to reach about 2045.70 M USD by 2021 from 1500.48 M USD in 2016, registering a Compounded Annual Growth ... Read More

  • Global Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017

    ... 2017’. The report provides insights into Gaucher's Disease epidemiology, Gaucher's Disease diagnosed patients, and Gaucher's Disease treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gaucher's Disease derived ... Read More

  • Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017

    ... 2017’. The report provides insights into Gaucher's Disease epidemiology, Gaucher's Disease diagnosed patients, and Gaucher's Disease treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Gaucher's Disease derived from ... Read More

  • Gaucher Disease Type III - Pipeline Review, H2 2016

    ... Gaucher Disease Type III (Genetic Disorders) pipeline landscape. Gaucher disease type III also known as chronic neuronopathic Gaucher disease (subacute form of neuronopathic Gaucher disease). Symptoms include mental deterioration, ataxia, and myoclonic seizures. The cause ... Read More

  • Gaucher's Disease - Pipeline Review, H2 2015

    ... therapeutic development for Gaucher's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ... Read More

  • Global Gaucher Disease Market 2015-2019

    ... in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out ... Read More

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog